In this study, we investigated to what extent the stability and transduction capacity of polyplexed DNA can be improved by optimizing the condensing peptide sequence. We have synthesized a small library of cationic peptides, at which the lysine/arginine ratio and the cation charge were varied. All peptides were able to compact DNA, at which polyplexes of short lysine-rich sequences were considerably larger than those of elongated or arginine-rich peptides (GM102 and GM202). In addition, the arginine-rich peptides GM102 and GM202 rendered the polyplexes resistant to plasma incubation or DNase I-mediated digestion. While all peptides were found to improve the transfection efficiency in HepG2 cells, only the GM102-and GM202-derived polyplexes could be specifically targeted to HepG2 cells by incorporation of a ligand-derivatized YKAK 8 WK peptide. We propose that GM102 and GM202 combine the advantage of small condensing peptides to give small-sized polyplexes with the superior stability of condensing polymers, which makes GM102 and GM202 excellent candidates for future in vivo gene therapy studies.
Introduction
Nonviral gene transfer has undergone considerable progress in recent years resulting in numerous reports on high and cell-specific transfection in vitro. The superior safety, the high flexibility and the ease of production make it better tailored for widespread clinical application than viral vectors. 1, 2 Basically, two types of nonviral vectors exist: cationic lipid-(lipoplexes) and polymer-based vectors (polyplexes). Lipoplexes have been optimized to give impressive expression levels in a broad range of cell lines and primary cells. In vivo these vectors have been utilized for topical transfection of the vascular wall, 3 tumor tissue, 4 muscle tissue 5 and hair follicles. 6 Systemic application of lipoplex vectors resulted mainly in alveolar and splenic transfection, which was tentatively attributed to adherence of the large-sized lipoplexes to endothelial proteoglycans of these highly vascularized organs. 7, 8 The smaller-sized and more hydrophilic polyplexes, in which DNA is compacted using cationic polymers, form a promising, more defined, alternative. Wu et al 9 were the first to describe effective in vitro and in vivo gene transfer of hepatocytes using poly-L-lysine-based polyplexes. 10 The transfection by poly-L-lysine-based polyplexes was moderately high, depended on polyplex size and geometry and could be enhanced by measures to prevent lysosomal degradation. [11] [12] [13] [14] Selective uptake by a broad range of cell types could be induced by incorporating homing devices for cell-specific receptors. 9, 10, 15, 16 Polyethyleneimine (PEI) [17] [18] [19] and dendrimer polyamido amines 20, 21 gave even higher transfection yields. The high transfection efficacy was explained by the intrinsic endosomolytic activity of these polymers, facilitating the escape of the DNA cargo into the cytosol. 20 A third class of condensing compounds entailed synthetic oligocations. 12, [22] [23] [24] [25] These small oligocations did not activate the complement system, 21 were nonaggregating, yielded small-sized polyplexes, 26 and gave polyplexes that were readily unpacked intracellularly. 16 Smith and co-workers reported efficient transfection of a variety of cell types by YKAK 8 WK-derived polyplexes to levels approximating those of adenoviral vectors. 12, 22 Still, reports of successful systemic in vivo application of lipo-and polyplexes are scarce, 27 which may be attributable to the low flexibility. In an attempt to improve their stability, more lipophilic condensing peptides 23, 24 have been developed as well as cysteine-containing peptides that could be stabilized by intermolecular disulfide crosslinking. 23 In search of more stable nonviral vectors that are adapted to in vivo conditions but share the beneficial properties of oligocation-based polyplexes, we have, in this study, explored an alternative strategy. A series of YKAK 8 WK peptide analogs was designed, in which lysine residues were partially replaced by arginines and the cationic charge was further increased to enhance the polyplex stability. We show that, although all of the condensing peptides were able to compact DNA, only the arginine-enriched peptides rendered the polyplexes stabile against plasma, DNase I digestion and in vivo conditions.
Results
In this study we describe the development of a modular polyplex system suited for in vivo gene transfer. Starting from the condensing peptide YKAK 8 WK, which was successfully applied for in vitro transfection of HepG2 cells by Gottschalk et al, 12 we have designed a series of analogs (for amino-acid sequences see Table 1 ). Three variables were included: the arginine content; the cationic charge; and the absence or presence of an SV40 nuclear location signal (NLS).
First, we have determined the ability of the cationic peptides to condense plasmid DNA (pCMC-LacZ) and to impair its electrophoretic mobility in a gel retardation assay. A typical DNA titration experiment showing the effect of increasing peptide-to-DNA charge ratios on the electrophoretic mobility of the DNA is depicted in Figure 1 . In essence, all peptides gave complete retardation of DNA at peptide-to-DNA charge ratios Z1.0, suggestive of effective compaction and charge neutralization of the DNA.
Physico-chemical characterization of the polyplexes
Previous studies have demonstrated that not only the size and polydispersity of the DNA vehicle but also the tendency to aggregate is dictated by the nature of the cationic polymer. 28 As the transfection efficiency relies heavily upon these parameters, we have characterized the polyplexes for polydispersity, size and aggregate formation. Polyplex polydispersity and geometry were determined by electron microscopic analysis of polyplex replicas. As can be appreciated from Figure 2a , condensation of DNA with the condensing peptides (charge ratio 1.0) furnished small, uniformly sized, spherical particles. The mean particle size of the polyplexes (charge ratio 1.0), as calculated from the EM photographs, ranged from 1371 to 5678 nm (Figure 2b) . Interestingly, GM100 and GM101 yielded the largest polyplexes (44710 and 5679 nm, respectively), while polyplexes of elongated or arginine-containing peptides (eg GM102) were approximately 20 nm. For comparison, PEI polyplexes in HBS were much larger (4100 nm) than oligopeptide-derived polyplexes (data not shown). Photon correlation spectroscopy confirmed the EM data (GM100: 64714 nm; GM202: 15711 nm) and demonstrated that the polyplexes are also small-sized under aqueous conditions. Likewise, polyplexes of GM102 that were incubated for 10 min at 371C with HBS or with murine plasma were not retained by a 100 nm pored filter, once again substantiating the small size of the condensates and demonstrating that polyplex aggregation of the polyplexes did not occur (data not shown).
The effect of the charge ratio on polyplex size, polydispersity and polyplex geometry was also studied. Interestingly, at a charge ratio of 0.5, DNA strands could be observed interconnecting isolated DNA condensates. At higher charge ratios (Z1.0) only completely condensed monodispersic polyplexes were found (data not shown).
Effect of the condensing peptide on the polyplex stability in murine plasma
In the next stage, we have evaluated the effect of the condensing peptide sequence on the polyplex integrity in HBS or in freshly isolated murine plasma. To monitor the polyplex stability, an ethidium bromide (EtBr) fluorescence assay was used that is based on the differential fluorescence of dsDNA-associated versus unbound EtBr. Upon full condensation, dsDNA is inaccessible to EtBr and the fluorescence level will be similar to that of unbound EtBr, whereas polyplex disintegration will translate into a detectable gain in fluorescence. The fluorescence of EtBr incubated polyplexes was normalized to that of free (0%) and pCMV-LacZ-associated EtBr (100%). The presence of HBS, plasma or peptide did not interfere with the fluorescence of unbound EtBr (data not shown). Figure 1 Effect of the peptide-to-DNA charge ratio on the electrophoretic mobility of DNA. Plasmid (208 ng/ml HBS) was mixed with GM102 at the indicated peptide-to-DNA charge ratio (0-1.5) and incubated for 30 min at 201C. Lane M contains the size reference (SMART ladder; Eurogentec, Brussels, Belgium). DNA condensates were electrophoresed on a 0.8% agarose gel, stained with EtBr and visualized under UV. Summarizing the results in Figure 3 , we may conclude that GM100-, GM101-and GM200-(the NLS analog of GM100) derived polyplexes were unstable in plasma. GM205 and GM212 (both NLS-containing peptides) gave partial protection (40-60%), while GM102 and GM202 (the NLS analog of GM102) conferred full protection against plasma-induced desintegration regardless of the charge ratio.
Polyplex stability against DNase I digestion
As a measure of polyplex stability against enzymatic degradation in vivo, we have investigated to what extent polyplexed DNA is protected against DNase I-induced digestion at 371C ( Figure 4 ). As a control for DNase I activity, we monitored the integrity of DNase I-treated DNA in time. Partial plasmid digestion could already be detected after 1 min of treatment and progressed to complete degradation within 60 min. Interestingly, the octalysine peptides GM100 and GM101 did not protect DNA against DNase I digestion at low charge ratios (o1.5), and conferred only partial protection at a charge ratio of 1.5. GM102-based polyplexes, however, appeared to be partially stable at a peptide-to-DNA ratio of 0.5, and were completely protected against DNase I digestion for more than 60 min at ratios 41.0.
Tissue distribution of GM102-based polyplexes
As the above data suggest that GM102 polyplexes may be better for in vivo gene transfer, we have investigated the in vivo behavior of the polyplexes. [
125 I]-pCMV-LacZ (5.2 mg) was polyplexed with GM102 to a charge ratio of 1.0, and intravenously injected into mice. The bulk of polyplexed DNA was rapidly cleared from the circulation ( Figure 5) . Importantly, only a minor portion of the administered radioactivity could be recovered in lung tissue. Apart from a significant accumulation in spleen and to a lesser extent in liver, the polyplexes distributed quite evenly over the body tissue. As a reference, the in vivo fate was studied of PEI-based polyplexes (Mw¼30 000; N:P ratio 4:1), which were reported to be stable under in vivo conditions. 4 Evidently, the distribution pattern is essentially similar to that of the GM102-based polyplexes, suggesting that these polyplexes have a similarly low tropism for lung tissue. polyplexes. GM212-derived polyplexes (104 ng DNA/ml, charge ratio 1.0) were prepared in HBS as described in Materials and methods. Polyplex replicas were prepared by platin/carbon evaporation and subsequently analyzed on a Philips E410 TEM microscope (bar length: 100 nm). (b) Effect of the condensing peptide sequence on polyplex size as determined by transmission electron microscopy. Polyplexes (104 ng DNA/ml, charge ratio 1.0) were prepared in HBS as described in Materials and methods. Polyplex replicas were prepared by platin/carbon evaporation and analyzed on a Philips E410 TEM microscope. Values are means7s.d. of 430 particles.
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Transfection of HEPG2 cells
Finally, we have assessed the transfection efficiency of the various polyplexes in HepG2 cells. The cells were transfected with polyplexed DNA, complexed with the various condensing peptides (pCMVluc; N:P ratio of 1:1). All condensing peptides improved gene transfer by fivefold as compared to uncomplexed DNA (24 430 versus 4640 RLU/mg for GM202 and naked DNA, respectively). However, transfection efficacies in HepG2 could be considerably improved by prior incorporation of KWK 8 AKY-Tris(GalNAc) 3 , a conjugate of GM100 and a high-affinity ligand for the asialoglycoprotein receptor (ie Tris(GalNAc) 3 ), into the polyplex. While the polyplexes per se gave a five-fold increase in transfection yield relative to the unpackaged control, the KWK 8 AKYTris(GalNAc) 3 -targeted polyplexes led to a 430-fold gain in transgene expression in HepG2s for the most stable (GM212 and GM202) polyplexes. Interestingly, incorporation of KWK 8 AKY-Tris(GalNAc) 3 in GM102-and GM100-based polyplexes did not change its transfection ability in HepG2s (Figure 6 ). The glycoconjugated peptide was not effective in A549 cells which do not express the asialoglycoprotein receptor (data not shown). Thus, KWK 8 AKY-Tris(GalNAc) 3 exerts its activity through the asialoglycoprotein receptor, but its stimulatory capacity relies heavily on the polyplex stability.
Discussion
In this study, we have designed cationic peptide analogs of the promising YKAK 8 WK peptide of Gottschalk et al 12 and tested them for their ability to form small-sized and Importantly, an optimal length of a condensing peptide may exist above which the transfection level drops due to an increased tendency of the polyplexes to aggregate, to activate the complement system, 30 to undergo opsonization 31 or to display a retarded intracellular unpackaging of the DNA cargo. 16 Secondly, introduction of an NLS in the condensing peptide may facilitate polyplex transport to the nucleus. 32, 33 Conceivably, insertion of alanine residues may render the peptide more flexible and hydrophobic, leading to more stable polyplexes. 23, 24, 30 Gel retardation analysis established that all peptides were able to retard the mobility of DNA at the predicted peptide-to-DNA charge ratio of 1.0. For the subsequent characterization studies, we decided to use low charge ratios of up to 1.5, as higher charge ratios may promote complement activation, 30 binding to proteoglycan-rich endothelium (lung) and opsonization. 31 The thus formed polyplexes appeared to be monodisperse at charge neutrality, and considerably smaller than PEI-derived polyplexes (13-56 nm versus 4100 nm, respectively). Interestingly, polyplexes of the K 8 motif containing GM100 and GM101 peptides tended to be larger (45-56 nm) than those of elongated or arginine-containing peptides (approx. 20 nm) both in the EM and in the photon correlation spectroscopy study. This is close to the minimum compaction size of a plasmid (15 nm), suggesting that the polyplexes probably contain only a few DNA copies per particle. Intriguingly, the size of peptide-derived polyplexes seems to be less sensitive toward the condensation conditions (eg DNA concentration, buffer, mixing protocol) than polymer-derived polyplexes. 11, 34 At low charge ratios, polyplexes consisted of multiple small condensation nuclei on an uncondensed DNA strand, which transgressed into spherical particles at higher charge ratio, suggesting that unlike cationic polymers, 11, 34 oligopeptides initiate DNA compaction at distinct condensation nuclei within the DNA strand.
A second requisite for successful in vivo gene transfer involves the stability of the polyplexes under in vivo conditions. 31 Although all polyplexes were found to be stable in HBS irrespective of their charge ratio, in the presence of plasma the polyplex stability appeared to depend on the peptide sequence and the charge ratio. Polyplexes based on the parent YKAK 8 WK peptide (eg GM100, 101 and 201) readily dissociated upon incubation with plasma, which will strongly limit their potential for in vivo gene transfer. Polyplexes based on the (KR) 4 peptides (eg GM102 and GM202) displayed a remarkable resistance against plasma-induced disintegration. In line with the earlier finding of Wadhwa et al 24 that polyplexes of linear and dimerized K 13 -containing peptides associated more avidly with DNA, our stability studies suggest that elongation of the peptides with multiple lysines or with the SV40-NLS indeed reduced the polyplex size and improved the polyplex stability in plasma.
The increased plasma stability of the arginine-containing peptides was accompanied by an improved stability against DNase I-induced digestion. 35, 36 Conversely, polyplexes of the parent peptides GM100 and GM101 were not only rapidly destabilized in murine plasma but also proved susceptible to enzymatic digestion. This is further substantiated by the in vivo fate of GM102 polyplexes in C57Bl mice. The GM102 polyplexes could be recovered in a broad range of tissues, with highest accumulation in spleen and liver and only marginal recovery in lung (o10%/g tissue). This contrasts favorably with most of the lipoplexes and polyplexes that tend to accumulate in alveolar tissue 27, 31 due to binding of the positively charged polyplexes to endothelial proteoglycans and to retention of (opsonized) aggregates in capillary vessels. The radioactivity distribution pattern concurs with that of PEI-derived polyplexes, which are reported as one of the most effective nonviral vectors in vivo. 37 Luciferase expression levels revealed that all complexes were able to enhance the transfection efficiency to the same level. Introduction of an NLS sequence did not lead to further improvement of the transfection efficiency, suggesting that translocation to the nucleus is not rate-limiting. By contrast, incorporation of an asialoglycoprotein receptor-specific ligand (GM300) into the GM100-derived polyplex to direct the vectors to the asialoglycoprotein receptor considerably enhanced the transfection of HepG2s. Strikingly, only the most stable polyplexes based on GM102 and GM202 did benefit from targeted delivery, possibly due to a more avid incorporation of the homing peptide into the polyplexes.
The in vivo data together with the favorable size, charge and (enzymatic) stability make GM102 or GM202 polyplexes two promising basic vectors for tissuespecific in vivo gene transfer.
Materials and methods
Materials
DNase I (RNAse free) was obtained from Pharmacia Biotech (Uppsala, Sweden), and heparin from Leo Vectors pCMV-lacZ (7.8 kb) was kindly provided by Dr Hoeben (Department of Molecular Virology, Leiden University, The Netherlands) and was purified twice on a CsCl density gradient before use. Purity was routinely checked by agarose gel electrophoresis in 0.5 Â TBE (45 mM Tris/borate, 1 mM EDTA, pH 8.0). Concentration and purity were determined by UV spectroscopy in TE (10 mM Tris-Cl, 1 mM EDTA, pH 7.6).
Synthesis and purification of cationic peptides
Synthetic peptides were made at a 10 mmol scale by solid-phase Fmoc peptide chemistry using TentagelS AC resins (Rapp, Tü bingen, Germany) on an Abimed 422 multiple peptide synthesizer (Abimed, Langenfeld, Germany) 38 in combination with 9-fluorenylmethoxycarbonyl-protected amino acids carrying trifluoroacetic acid (TFA)-labile side-chain protection groups. Cleavage of the peptides and removal of the side-chain-protecting groups was performed with TFA/water 19/1 (v/v) for 2.5 h. For tryptophan-containing peptides (GM100 and GM300), ethanethiol (5%) was added to the cleavage cocktail. Peptides were isolated and purified by repeated ether precipitations, dissolved in 10% acetic acid and lyophilized. Aliquots of the peptides were analyzed for purity by HPLC and mass spectrometry. Lyophilized peptides were dissolved in double-distilled water for concentration determination at 293.5 nm in 10 mM NaOH. Dissolved peptides were lyophilized and aliquoted at À201C.
Synthesis of K 8 -Tris(GalNAc) 3 (GM300)
KWK 8 AKYC-S-acetyl-methylacetamide was synthesized by solid-phase chemistry as described above. Compound 1 (N-2-bromoacetyl-glycinyl-tris {(1-[2-(2-aminoethoxy) ethoxy]ethoxy-2-acetamido-2-deoxy-b-D-galactosamine)-carboxyethoxymethyl)}methane or Tris(GalNAc) 3 ) was synthesized as previously described 39 and reacted with bromoacetic acid as follows. The cluster glycoside (18 mmol) was dissolved in 1 ml of DMF and diisopropyl ethanolamine (18 mmol, 3.1 ml) was added. Subsequently, bromoacetic acid (36 mmol, 5 mg) was dissolved in DMF (250 ml) and diisopropyl ethanolamine (36 mmol, 6.3 ml), HOBT (1-hydroxybenzotriazole, 36 mmol, 5 mg) and PyBOP (benzotriazol-1-yl-oxytripyrrolino phosphonium hexafluorphosphate, 36 mmol, 19 mg) were added. The mixture was added to the dissolved cluster glycoside and incubated for 18 h on ice under gentle agitation. After reaction, the mixture was lyophilized, the crude residue was chromatographed over an LH20 column using MeOH as eluent. Peak fractions were pooled and lyophilized after which the product was purified by RP-HPLC (C18 column; 0.1% TFA to 50% acetonitril in 30 min). Compound 1 (Figure 7 ) was characterized by mass spectroscopy (mass found: 1544.2; calculated mass C 61 H 109 BrN 8 O 32 : 1544.6) and NMR.
In the conjugation step, compound 1 (0.7 mmol) in 0.25 ml of phosphate buffer (0.1 M, pH 6.0) was reacted with the S-acetyl-methylacetamide-derivatized peptide (0.56 mmol in 0.25 ml phosphate buffer). Hydrazine (15 ml of a 2 M stock solution in phosphate buffer) was added to deprotect the S-acetyl group of the peptide and to commence the conjugation. Progression of the conjugation reaction was monitored daily by RP-HPLC analysis (C18 column, flow: 1 ml/min; gradient elution: 0.1% TFA to 100% acetonitril in 30 min). After completion of the reaction (1 week), the mixture was purified by semiquantitative RP-HPLC (same column and elution conditions) and the pooled peak fractions with the putative product lyophilized. Yield of the conjugation reaction: 0.15 mmol (27%). Mass found: 3205.6.
Polyplex preparation
Polyplexes were prepared as follows. Peptide was dissolved in HEPES-buffered saline (150 mM NaCl, 10 mM HEPES, pH 7.6; HBS) to a concentration of 1 mg/ml and added dropwise under constant agitation into a solution of pCMV-LacZ (1 pmol/25 ml HBS) until the aimed peptide-to-DNA charge ratio was reached. The final volume was adjusted to 50 ml with HBS and the peptide/DNA mixture was incubated for 30 min at room temperature. The extent of DNA condensation was checked by agarose gel electrophoresis in 0.5 Â TBE.
Size analysis of the polyplexes
Small droplets of polyplex solution were floated on freshly splitted mica and allowed to dry at room temperature. These samples were placed in a Balzers 400D evaporating machine, which was evacuated to a pressure of 2.0 Â 10 À5 Pa. The specimens were replicated by evaporation of platin/carbon (2.5 mm) at an angle of 301 followed by carbon evaporation (30 mm) at an angle of 901. After replication, the specimens were removed from the vacuum chamber and submerged in distilled water. The floating replicas were collected on 400 mesh copper grids and examined and photographed in a Philips EM410 Electron Microscope. Polyplex size was estimated from comparison with calibration grids. For size determination, the diameter of 430 particles from two EM photos was measured. EM particle sizes were verified by photon correlation spectroscopy (Malvern Instruments, Malvern, UK) at 251C and at a 901 angle. Mass-weighed averages of 10 size measurements are given. Radiolabeled polyplexes (104 ng/ml; prepared 40 ) were incubated with HBS or freshly isolated murine plasma (1:1) for up to 10 min at 371C. After incubation, samples were diluted 1:5 with HBS and loaded onto UTRAFREE microfuge filters. Samples were centrifuged for 15 min at 2000 r.p.m. in an Eppendorf microcentrifuge. The filtrates were collected and the radioactivity of the samples was determined using a g-counter.
Determination of polyplex integrity
Polyplexes were incubated for 0-60 min at 371C with HBS or freshly isolated murine plasma (dilution 1:1 with HBS) at a concentration of 420 ng/50 ml. After incubation, samples (5 ml) were taken and added to 45 ml of HBS in Costar microtiter fluorescence plates. Next, EtBr (100 ml of a 0.2 mM solution in HBS) was added and the fluorescence was immediately quantified using an HTS 7000 fluorescence spectrophotometer (Perkin Elmer, USA) equipped with excitation and emission filters of 492 and 595 nm, respectively. Values were corrected for background fluorescence and normalized to the fluorescence of pCMV-LacZ in the absence of peptide. The presence of the peptides or murine plasma did not interfere with the fluorescence of EtBr.
DNase I protection assay
Polyplexes were incubated at 371C for 0-60 min with DNase I (7.5 ng in 15 ml of DNase I buffer containing 40 mM Tris-HCl and 6 mM MgCl 2 ; pH 7.5). The reaction was terminated by the addition of EDTA (8.33 ml, 0.5 M, pH 8.0). After addition of SDS (3 ml, 1%), the DNA was extracted from the samples using phenol/chloroform (1:1 v/v), and precipitated with sodium acetate/ethanol. Precipitated DNA was resuspended in TE (25 ml) and subjected to agarose gel electrophoresis. DNA was visualized under UV after EtBr staining.
Determination of serum clearance and tissue distribution
Male C57Bl/6 mice (8-10 weeks, 20-28 g) were injected with radioiodinated polyplexes (1 pmol in 250 ml HBS; charge ratio 1.0) in the inferior vena cava. After 10 min, the mice were killed, the tissues were excised and tissueassociated radioactivity was determined. Radioactivity in the tissues was corrected for radioactivity in serum present in the tissue at the time of sampling.
Targeted transfection of HEPG2 cells in vitro
Polyplexes of pCMV-Luc (2.5 mg/25 ml HBS, charge ratio 1.0) were prepared as described above. HepG2 cells were grown to 70% confluency. For transfection, DNA-peptide complexes (2 mg/well) were added to the wells (in duplo) in DMEM culture medium (10% FBS). The medium was replaced after 18 h. Cells were harvested and assayed for luciferase activity 41 and protein content (BCA) at 48 h after transfection. The targeted transfection study was performed analogously, but now the polyplexes were, after condensation, incubated with K 8 -Tris(GalNAc) 3 for 30 min (to a final concentration of 5% of the total peptide).
